A detailed history of True Wealth Design, LLC transactions in Biogen Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 4 shares of BIIB stock, worth $605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$605
Previous $928,000 16.38%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $190 - $236
-1 Reduced 20.0%
4 $928,000
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $424 - $535
2 Added 66.67%
5 $1.08 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $222 - $267
-1 Reduced 25.0%
3 $777,000
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $1,101 - $1,272
-4 Reduced 50.0%
4 $1.14 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $1,026 - $1,169
4 Added 100.0%
8 $2.23 Million
Q4 2022

Feb 15, 2023

BUY
$252.44 - $306.72 $1,009 - $1,226
4 New
4 $1.11 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.